Cargando…

Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study

This study aimed to determine the effectiveness and safety of varenicline versus NRT for smoking cessation in people with neurodevelopmental disorders, compared to those without, at up to four years after exposure. We analysed electronic medical records from the Clinical Practice Research Datalink u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itani, Taha, Rai, Dheeraj, Jones, Tim, Taylor, Gemma M. J., Thomas, Kyla H., Martin, Richard M., Munafò, Marcus R., Davies, Neil M., Taylor, Amy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925148/ https://www.ncbi.nlm.nih.gov/pubmed/31862899 http://dx.doi.org/10.1038/s41598-019-54727-5

Ejemplares similares

Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records
por: Itani, Taha, et al.
Publicado: (2019)

What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
por: Davies, Neil M, et al.
Publicado: (2015)

The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records
por: Taylor, Gemma MJ, et al.
Publicado: (2017)

Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study
por: Thomas, Kyla H., et al.
Publicado: (2020)

The effects of prescribing varenicline on two‐year health outcomes: an observational cohort study using electronic medical records
por: Davies, Neil M., et al.
Publicado: (2018)

Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders
por: Taylor, Gemma M J, et al.
Publicado: (2019)

The Food and Drug Administration and varenicline: should risk communication be improved?
por: Davies, Neil M., et al.
Publicado: (2016)

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial
por: Tulloch, Heather E., et al.
Publicado: (2016)

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011)

How to compare instrumental variable and conventional regression analyses using negative controls and bias plots
por: Davies, Neil M, et al.
Publicado: (2017)

Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014)

Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)

Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
por: Madae’en, Saba, et al.
Publicado: (2020)

Correction: Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records
Publicado: (2019)

Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan
por: Chang, Po-Yin, et al.
Publicado: (2019)

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial
por: Hajek, Peter, et al.
Publicado: (2013)

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
por: Ramon, Josep M, et al.
Publicado: (2014)

Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial
por: Sifat, Munjireen, et al.
Publicado: (2023)

A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
por: Narayan, A. Lakshmi, et al.
Publicado: (2015)

2532: Predictive metabolism studies of varenicline and implications of its metabolites in nicotine addiction
por: Thompson, Keeshaloy, et al.
Publicado: (2018)

377 Randomized Placebo-controlled Trial to Test the Efficacy of genetically informed biomarker Nicotine Metabolite Ratio (NMR), and transdermal nicotine replacement therapy (NRT) versus varenicline
por: Amadi-Onuoha, Obumneke
Publicado: (2023)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial
por: Davis, James M., et al.
Publicado: (2023)

Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice
por: Lee, Lauren J., et al.
Publicado: (2018)

Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study
por: Attwood, Angela S, et al.
Publicado: (2014)

Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α(4)β(2)-receptor partial agonist varenicline
por: Batsikadze, G., et al.
Publicado: (2017)

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat
por: Garcia-Rivas, Vernon, et al.
Publicado: (2019)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
por: Thomas, Kyla H, et al.
Publicado: (2015)

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
por: Wouda, Jelte A., et al.
Publicado: (2011)

Recent Innovations at Nicotine & Tobacco Research
por: Munafò, Marcus
Publicado: (2015)

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
por: Carlson, Eric C., et al.
Publicado: (2023)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
por: Ebbert, Jon O, et al.
Publicado: (2010)

Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020)

The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
por: Bullen, Chris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8jdhokiqlt8pphgcgc2s0ug3l8